The data of the Association of Mutual Funds in India (AMFI) shows that a regular plan dominates the SIP and has better longevity than a direct plan. Read onto find out more.

In a press release, Welspun India stated that the company is set to work with Target Corporation in the USA to achieve business growth. Reacting to the announcements made post the meeting held of its board of directors, its stock jumped by more than 11 per cent. 

The shares of UPL Ltd climbed over 8 per cent on Friday, touching its 52-week high of Rs 764.45 per share, after JP Morgan released a coverage report on the company, highlighting its growth potential. 

Alembic Pharmaceuticals Limited, a leading pharmaceutical company, announced today that it has received approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Lurasidone Hydrochloride tablets (20 mg, 40 mg, 60 mg, 80 mg, and 120 mg).  

Sun Pharma Advanced Research Company Ltd (SPARC), a global pharmaceutical company announced on Friday that it has achieved success in phase 3 trial of its investigational drug namely, PDP-716 ophthalmic suspension.   

A weekly summary of the most important economic news affecting the stock market

In a first-ever development, Jindal Stainless Limited (JSL) announced that CRISIL Ratings has assigned ‘CRISIL A+/stable’ to the long-term credit facilities of the company. The present rating is three notches higher than the earlier ratings.   

In today's trading session, the market is depicting a volatile performance. However, the stock, which is attracting the eyes of the investors, is Yasho Industries.  

Dr Reddy’s Laboratories on Friday announced that the first consignment of imported doses of Sputnik-V vaccine was administered in Hyderabad today as part of a limited pilot soft-launch. The consignment of doses that landed in India on May 01, 2021, received regulatory clearance from Central Drugs Laboratory (CDL, Kasauli) on May 13, 2021.   

Pharmaceutical major Lupin announced that the company’s board of directors has recommended a dividend at 325 per cent equivalent to Rs 6.50 per equity share of the face value of Rs 2 each for FY21.